IONS
Ionis Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
7.08 / 10
Outperform
Analyst consensus is 75% bullish (25% Strong Buy, 50% Buy) with a weighted rating of 6.55, though historical win rates vary. Fund‑flow score is strong at 7.61, yet inflow trends are negative across all size segments, and the stock is down 5.8%.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
25%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionPiper Sandler
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for IONS?
- IONS holds a Bullish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.08/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
